Articles published in Brain Disorders & Therapy have been cited by esteemed scholars and scientists all around the world. Brain Disorders & Therapy has got h-index 12, which means every article in Brain Disorders & Therapy has got 12 average citations.

Following are the list of articles that have cited the articles published in Brain Disorders & Therapy.

  2021 2020 2019 2018 2017

Year wise published articles

46 13 13 11 16

Year wise citations received

103 84 90 74 83
Journal total citations count 713
Journal h-index 12
Important citations

 This file was downloaded from: http://eprints. qut. edu. au/79677

A shared comparison of diabetes mellitus and neurodegenerative disorders

Colony stimulating factors in the nervous system

 Sargramostim (rhu GM-CSF) as Cancer Therapy (Systematic Review) and An Immunomodulator. A Drug Before Its Time?

Biochemistry & Molecular Biology Letters

 Innate Immune System Activation and Neuroinflammation in Down Syndrome and Neurodegeneration: Therapeutic Targets or Partners?

Anterior Spinal Artery Thrombosis Following Trivial Trauma in A Young Girl-Case Report and Review of Literature

Predicting the severity of the course of spinal cord injury

 Research & Reviews: Journal of Medical and Health Sciences

Features of intensive care of spinal cord injury

Correlation of the vascular factor with the severity of the condition of patients with spinal cord injury

Pharmacological prospects for the treatment of spinal cord injury in the acute and early periods

ANALYSIS OF INTENSIVE CARE AND THE CAUSES OF MORTALITY IN PATIENTS WITH SPINAL INJURY

Features of blood circulation in the vertebrobasilar basin in patients with cervical spinal cord injury

 Innovative approaches in the field of cardiology

Analysis of results of the surgical treatment of the spinal cord injury (step by step)

Construction and identification of GCA fusion gene recombinant BCG shuttle plasmid

Expression of GM-CSF and Epstein-Barr virus LMP2 A fusion gene and its anti-tumor properties

Pro-inflammatory cytokine GM-CSF improves learning/memory and brain pathology in Dp16 down syndrome mice and improves learning/memory in wild-type mice

Drug treatments in development for Alzheimer’s disease